Pfizer Asks FDA To Expand Bivalent Booster Eligibility To Children Aged 5 To 11

The AP (9/26) reports, “Pfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to 11.” If the FDA approves, children “would start getting a kid-sized dose of the new omicron-targeted formula when it was t...